93 related articles for article (PubMed ID: 26391645)
1. CXCR1 knockdown improves the sensitivity of osteosarcoma to cisplatin.
Han XG; Du L; Qiao H; Tu B; Wang YG; Qin A; Dai KR; Fan QM; Tang TT
Cancer Lett; 2015 Dec; 369(2):405-15. PubMed ID: 26391645
[TBL] [Abstract][Full Text] [Related]
2. CXCR1/Akt signaling activation induced by mesenchymal stem cell-derived IL-8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis.
Du L; Han XG; Tu B; Wang MQ; Qiao H; Zhang SH; Fan QM; Tang TT
Cell Death Dis; 2018 Jun; 9(7):714. PubMed ID: 29915309
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-8 Induces Expression of FOXC1 to Promote Transactivation of CXCR1 and CCL2 in Hepatocellular Carcinoma Cell Lines and Formation of Metastases in Mice.
Huang W; Chen Z; Zhang L; Tian D; Wang D; Fan D; Wu K; Xia L
Gastroenterology; 2015 Oct; 149(4):1053-67.e14. PubMed ID: 26065367
[TBL] [Abstract][Full Text] [Related]
4. TIMP3 Overexpression Improves the Sensitivity of Osteosarcoma to Cisplatin by Reducing IL-6 Production.
Han XG; Mo HM; Liu XQ; Li Y; Du L; Qiao H; Fan QM; Zhao J; Zhang SH; Tang TT
Front Genet; 2018; 9():135. PubMed ID: 29731768
[TBL] [Abstract][Full Text] [Related]
5. CXCR1 promotes malignant behavior of gastric cancer cells in vitro and in vivo in AKT and ERK1/2 phosphorylation.
Wang J; Hu W; Wu X; Wang K; Yu J; Luo B; Luo G; Wang W; Wang H; Li J; Wen J
Int J Oncol; 2016 May; 48(5):2184-96. PubMed ID: 26983663
[TBL] [Abstract][Full Text] [Related]
6. TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma.
Li C; Cai J; Ge F; Wang G
Int J Mol Med; 2018 Oct; 42(4):1799-1808. PubMed ID: 30015899
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of Akt sensitizes osteosarcoma cells to apoptosis induced by cisplatin treatment.
Zhang G; Li M; Zhu X; Bai Y; Yang C
Int J Mol Sci; 2011; 12(5):2994-3005. PubMed ID: 21686164
[TBL] [Abstract][Full Text] [Related]
8. CXC receptor-1 silencing inhibits androgen-independent prostate cancer.
Shamaladevi N; Lyn DA; Escudero DO; Lokeshwar BL
Cancer Res; 2009 Nov; 69(21):8265-74. PubMed ID: 19861539
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-8/CXCL8 is a growth factor for human lung cancer cells.
Zhu YM; Webster SJ; Flower D; Woll PJ
Br J Cancer; 2004 Nov; 91(11):1970-6. PubMed ID: 15545974
[TBL] [Abstract][Full Text] [Related]
10. Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway.
Zhou J; Yi L; Ouyang Q; Xu L; Cui H; Xu M
Cell Signal; 2014 Dec; 26(12):2896-902. PubMed ID: 25200966
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-32 stimulates osteosarcoma cell invasion and motility via AKT pathway-mediated MMP-13 expression.
Zhou Y; Hu Z; Li N; Jiang R
Int J Mol Med; 2015 Jun; 35(6):1729-33. PubMed ID: 25846944
[TBL] [Abstract][Full Text] [Related]
12. [Adenovirus mediated antisense c-myc gene on the chemotherapy sensitivity of osteosarcoma cells to cisplatin].
Yang DS; Xie XK; Ye ZM; Tao HM
Zhonghua Wai Ke Za Zhi; 2005 Jun; 43(12):799-802. PubMed ID: 16083584
[TBL] [Abstract][Full Text] [Related]
13. Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma.
Orosco A; Fromigué O; Bazille C; Entz-Werle N; Levillain P; Marie PJ; Modrowski D
Cancer Res; 2007 Apr; 67(8):3708-15. PubMed ID: 17440083
[TBL] [Abstract][Full Text] [Related]
14. Concurrent blockade of NF-κB and Akt pathways potentiates cisplatin's antitumor activity in vivo.
Sun H; Zheng X; Wang Q; Yan J; Li D; Zhou Y; Lin Y; Zhang L; Wang X
Anticancer Drugs; 2012 Nov; 23(10):1039-46. PubMed ID: 22760211
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of CABYR-a/b increases chemosensitivity of human non-small cell lung cancer cells through inactivation of Akt.
Qian Z; Li M; Wang R; Xiao Q; Wang J; Li M; He D; Xiao X
Mol Cancer Res; 2014 Mar; 12(3):335-47. PubMed ID: 24362251
[TBL] [Abstract][Full Text] [Related]
16. Enhancement effect of adenovirus-mediated antisense c-myc and caffeine on the cytotoxicity of cisplatin in osteosarcoma cell lines.
Xie XK; Yang DS; Ye ZM; Tao HM
Chemotherapy; 2009; 55(6):433-40. PubMed ID: 19996588
[TBL] [Abstract][Full Text] [Related]
17. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
Tu B; Du L; Fan QM; Tang Z; Tang TT
Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
[TBL] [Abstract][Full Text] [Related]
18. The CXCR1 tail mediates beta1 integrin-dependent cell migration via MAP kinase signaling.
Liu-Bryan R; Pay S; Schraufstatter IU; Rose DM
Biochem Biophys Res Commun; 2005 Jun; 332(1):117-25. PubMed ID: 15896307
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiles classify human osteosarcoma xenografts according to sensitivity to doxorubicin, cisplatin, and ifosfamide.
Bruheim S; Xi Y; Ju J; Fodstad O
Clin Cancer Res; 2009 Dec; 15(23):7161-9. PubMed ID: 19920113
[TBL] [Abstract][Full Text] [Related]
20. Heat shock protein 27 protects L929 cells from cisplatin-induced apoptosis by enhancing Akt activation and abating suppression of thioredoxin reductase activity.
Zhang Y; Shen X
Clin Cancer Res; 2007 May; 13(10):2855-64. PubMed ID: 17504983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
